Global Consensus Position Statement on the Use of Testosterone Therapy for Women

J Clin Endocrinol Metab. 2019 Oct 1;104(10):4660-4666. doi: 10.1210/jc.2019-01603.

Abstract

This Position Statement has been endorsed by the International Menopause Society, The Endocrine Society, The European Menopause and Andropause Society, The International Society for Sexual Medicine, The International Society for the Study of Women's Sexual Health, The North American Menopause Society, The Federacion Latinoamericana de Sociedades de Climaterio y Menopausia, The Royal College of Obstetricians and Gynecologists, The International Society of Endocrinology, The Endocrine Society of Australia, and The Royal Australian and New Zealand College of Obstetricians and Gynecologists.

Publication types

  • Consensus Development Conference
  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androgens / therapeutic use*
  • Female
  • Humans
  • Off-Label Use
  • Postmenopause
  • Premenopause
  • Sexual Dysfunction, Physiological / diagnosis
  • Sexual Dysfunction, Physiological / drug therapy*
  • Sexual Dysfunction, Physiological / metabolism
  • Sexual Dysfunctions, Psychological / diagnosis
  • Sexual Dysfunctions, Psychological / drug therapy*
  • Sexual Dysfunctions, Psychological / metabolism
  • Testosterone / metabolism
  • Testosterone / therapeutic use*

Substances

  • Androgens
  • Testosterone